Immune persistence of an inactivated poliovirus vaccine derived from the Sabin strain: a 10-year follow-up of a phase 3 study

BACKGROUND: In a previous phase 3 clinical trial, we showed that an inactivated poliovirus vaccine derived from the Sabin strain (sIPV) can induce neutralising antibodies against currently circulating and reference wild poliovirus strains. However, the immune persistence of sIPV remains to be evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Lei, Ying, Zhifang, Cai, Wei, Wang, Jianfeng, Zhou, Jian, Yang, Huijuan, Gao, Jingxia, Zhao, Zhimei, Liu, Jing, Ouyang, Shengjie, Song, Shaohui, Shen, Fei, Zhao, Ruirui, Xu, Lilan, Dai, Xiaohu, Wu, Yanan, Li, Weidong, Li, Changgui, Liao, Guoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514427/
https://www.ncbi.nlm.nih.gov/pubmed/37745024
http://dx.doi.org/10.1016/j.eclinm.2023.102151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514427/
https://www.ncbi.nlm.nih.gov/pubmed/37745024
http://dx.doi.org/10.1016/j.eclinm.2023.102151

Ejemplares similares